Publicou 4 edições por ano
ISSN Imprimir: 1050-6934
ISSN On-line: 1940-4379
Indexed in
Rubella and Congenital Rubella (German Measles)
RESUMO
Rubella, also known as German measles, is usually a very mild infection that can have devastating effects in certain instances. It is a pleomorphic RNA virus in the Togaviridae family of the genus Rubivirus. It typically causes a scarletiniform rash, cervical lymphadenopathy, and mild constitutional symptoms, but in older children and adults, especially women, it may be more severe, with joint involvement and purpuric rash. Infection during the first 12 weeks of pregnancy results in congenital infection and/or miscarriage in 80-90% of cases. The congenital rubella syndrome (CRS) involves multiple organ systems and has a long period of active infection and virus shedding in the postnatal period. For these reasons, the rubella vaccine program was instituted in 1969, and the incidence of rubella infection in the United States has since declined by 99%. Rubella has been recognized as a disease for approximately 200 years, and it has since been found that humans are the only natural reservoir for the rubella virus. Virus is present in nasopharyngeal secretions, blood, feces, and urine during the clinical illness, although patients with subclinical disease are also infectious. The virus is spread via oral droplets and is shed in the nasopharynx for approximately 7 days before and after the rash is visible. CRS includes a configuration of anomalies, including nerve deafness, cataracts, cardiac anomalies (usually pulmonary artery and valvular stenosis, and patent ductus arteriosis), and mental retardation, with late complications including diabetes, thyroid disease, growth hormone deficiency, and progressive panencephalitis. In 1969, the first rubella vaccine was licensed for use, and the Centers for Disease Control and Prevention (CDC) began its National Congenital Rubella Syndrome Registry. As required under the National Childhood Injury Act, all healthcare providers in the United States who administer any vaccine shall, prior to administration of the vaccine, provide a copy of the Vaccine Information Statements (VIS) produced by the CDC to the parent or legal representative of any child to whom the provider intends to administer such vaccine, or to any adult to whom the provider intends to administer such vaccine. Despite efforts to vaccinate children, CRS continues to occur in the United States. Hispanic infants have an increased risk of CRS. HIV-1infected children with a preserved immune system and MMR immunization had a good response to rubella vaccine. In contrast, those in more advanced categories for HIV infection responded poorly.
Issues of risk, choice, and chance are central to the controversy over the MMR vaccine that erupted in the UK in 1998, and has continued into the new millennium. An important contribution to the MMR controversy has come from the parents of autistic children, some of whom reject the notion that this disorder is a random genetic misfortune and insist that it is, at least in part, the result of some environmental insult, such as MMR vaccinations.
-
Riahi Siavash, Pourbasheer Eslam, Dinarvand Rassoul, Ganjali Mohammad Reza, Norouzi Parviz, Exploring QSARs for Antiviral Activity of 4-Alkylamino-6-(2-hydroxyethyl)-2-methylthiopyrimidines by Support Vector Machine, Chemical Biology & Drug Design, 72, 3, 2008. Crossref
-
Zhao Li-Hong, Ma Yu-Yan, Wang Hong, Zhao Shu-Ping, Zhao Wei-Ming, Li Hua, Wang Lei-Yi, Establishment and Application of a TaqMan Real-Time Quantitative Reverse Transcription-Polymerase Chain Reaction Assay for <italic>Rubella Virus</italic> RNA, Acta Biochimica et Biophysica Sinica, 38, 10, 2006. Crossref
-
Edwards P., The use of parallel chemistry for the generation of micromolar hits against biological targets, Drug Discovery Today, 13, 5-6, 2008. Crossref
-
Mugnaini Claudia, Petricci Elena, Botta Maurizio, Corelli Federico, Mastromarino Paola, Giorgi Gianluca, Synthesis and biological evaluation of 4-alkylamino-6-(2-hydroxyethyl)-2-methylthiopyrimidines as new rubella virus inhibitors, European Journal of Medicinal Chemistry, 42, 2, 2007. Crossref
-
Cohen D., Muhsen Kh., Aboudy Y., Harari H., Mendelson E., Green M.S., Use of rubella seroepidemiological data for assessment of previous vaccination policy and for decision making in response to epidemics in Israel, Vaccine, 24, 27-28, 2006. Crossref
-
Weston William L., Lane Alfred T., Morelli Joseph G., Viral Infections, in Color Textbook of Pediatric Dermatology, 2007. Crossref
-
Sarkar Rashmi, Nair Vivek, Sinha Surabhi, Garg Vijay K, Rodriguez David A, Infectious Diseases, in Treatments for Skin of Color, 2011. Crossref
-
Mushahwar Isa K., Rubella Virus: Molecular Composition, Pathogenesis, Diagnosis, and Control, in Congenital and Other Related Infectious Diseases of the Newborn, 13, 2006. Crossref
-
Weston William L., Lane Alfred T., Morelli Joseph G., Infecciones víricas, in Dermatología pediátrica, 2008. Crossref
-
Türkmen Karaağaç Aysu, İnci Yıldırım Ayşe, “Rubella seroprevalence of the 9–15 years old female children with congenital heart anomalies: Is vaccination necessary at puberty?’’, Pediatric Infectious Disease, 6, 3, 2014. Crossref
-
van Helden Josef, Grangeot-Keros Liliane, Vauloup-Fellous Christelle, Vleminckx Renaud, Masset Frédéric, Revello Maria-Grazia, Evaluation of fully automated assays for the detection of Rubella IgM and IgG antibodies by the Elecsys® immunoassay system, Journal of Virological Methods, 199, 2014. Crossref
-
Atangana Abdon, Alkahtani Badr Saad T., Modeling the spread of Rubella disease using the concept of with local derivative with fractional parameter, Complexity, 21, 6, 2016. Crossref
-
Dontigny Lorraine, Arsenault Marc-Yvon, Martel Marie-Jocelyne, Biringer Anne, Cormier Johanne, Delaney Martina, Gleason Tom, Leduc Dean, Martel Marie-Jocelyne, Penava Debbie, Polsky Joshua, Roggensack Anne, Rowntree Carol, Wilson Ann Kathleen, Rubéole au cours de la grossesse, Journal of Obstetrics and Gynaecology Canada, 30, 2, 2008. Crossref
-
Dontigny Lorraine, Arsenault Marc-Yvon, Martel Marie-Jocelyne, Biringer Anne, Cormier Johanne, Delaney Martina, Gleason Tom, Leduc Dean, Martel Marie-Jocelyne, Penava Debbie, Polsky Joshua, Roggensack Anne, Rowntree Carol, Wilson Ann Kathleen, Rubella in Pregnancy, Journal of Obstetrics and Gynaecology Canada, 30, 2, 2008. Crossref
-
Chen Jin-ling, Ge Yi-yue, Zhang Jie, Qiu Xiao-yan, Qiu Jing-fan, Wu Jiang-ping, Wang Yong, Sinai Anthony, The Dysfunction of CD4+CD25+ Regulatory T Cells Contributes to the Abortion of Mice Caused by Toxoplasma gondii Excreted-Secreted Antigens in Early Pregnancy, PLoS ONE, 8, 7, 2013. Crossref
-
Thaller Raffaella, Pancallo Daniella, Gaudio Mariarosa, Valutazione di un kit per la rilevazione delle IgM anti-rosolia. Importanza della seconda metodica IgM nella diagnosi sierologica, La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine, 12, 3, 2016. Crossref
-
Mojadadi Mohammad-Shafi, Mahmoodabadi Najmeh, Lal-Kargar Melika, Elyasi Hossein, Seroepidemiology of Rubella Among Female Students of Sabzevar University of Medical Sciences in 2014, Journal of Sabzevar University of Medical Sciences, 23, 6, 2017. Crossref
-
Aly Gamal Samy, Abdel-Hady Hesham, Ibrahim Maged Z., Congenital Viral Infections, in Viral Infections in Children, Volume I, 2017. Crossref
-
Dontigny Lorraine, Arsenault Marc-Yvon, Martel Marie-Jocelyne, RETIRED: No. 203-Rubella in Pregnancy, Journal of Obstetrics and Gynaecology Canada, 40, 8, 2018. Crossref
-
Dontigny Lorraine, Arsenault Marc-Yvon, Martel Marie-Jocelyne, Archivée: No 203-Rubéole au cours de la grossesse, Journal of Obstetrics and Gynaecology Canada, 40, 8, 2018. Crossref
-
Wondimeneh Yitayih, Tiruneh Moges, Ferede Getachew, Abera Birhanu, Workineh Meseret, Birhanie Meseret, Tessema Belay, Rubella virus infections and immune status among pregnant women before the introduction of rubella vaccine in Amhara Regional State, Ethiopia, International Journal of Infectious Diseases, 76, 2018. Crossref
-
Mankertz Annette, Röteln, in S2k-Leitlinie - Labordiagnostik schwangerschaftsrelevanter Virusinfektionen, 2014. Crossref
-
Navya Attuluri, Profiling of Audiological Characteristics in Infants with Congenital Rubella Syndrome, Journal of Otolaryngology-ENT Research, 7, 6, 2017. Crossref
-
Garzuly Ferenc, Schneider Ferenc, Iványi János László, Nagy Zsuzsanna, Varga Mariann, Sütő Krisztián, Tolvaj Balázs, Kálmán Bernadette, Changing times – changing diseases. Review of the neuropathological autopsy documentations at the Markusovszky University Teaching Hospital (1964–2014), Orvosi Hetilap, 155, 43, 2014. Crossref
-
Korkmaz Hüseyin Anıl, Ermiş Çağatay, A case of immune-mediated type 1 diabetes mellitus due to congenital rubella ınfection, Annals of Pediatric Endocrinology & Metabolism, 24, 1, 2019. Crossref
-
Baleanu Dumitru, Mohammadi Hakimeh, Rezapour Shahram, A mathematical theoretical study of a particular system of Caputo–Fabrizio fractional differential equations for the Rubella disease model, Advances in Difference Equations, 2020, 1, 2020. Crossref
-
Shuid Ahmad Naqib, Jayusman Putri Ayu, Shuid Nazrun, Ismail Juriza, Kamal Nor Norazlin, Mohamed Isa Naina, Association between Viral Infections and Risk of Autistic Disorder: An Overview, International Journal of Environmental Research and Public Health, 18, 6, 2021. Crossref
-
PAGONENDJI Marilou S., GOUANDJIKA-VASILACHE Ionela, CHARPENTIER Emilie, SAUSY Aurélie, LE FAOU Alain, DUVAL Raphaël E., HÜBSCHEN Judith M., Rubella epidemiology in the Central African Republic, 2015-2016 and molecular characterization of virus strains from 2008-2016, International Journal of Infectious Diseases, 111, 2021. Crossref
-
Ilkow Carolina S, Willows Steven D, Hobman Tom C, Rubella virus capsid protein: a small protein with big functions, Future Microbiology, 5, 4, 2010. Crossref
-
Mahdy A.M.S., Mohamed M.S., Lotfy Kh., Alhazmi M., El-Bary A.A., Raddadi M.H., Numerical solution and dynamical behaviors for solving fractional nonlinear Rubella ailment disease model, Results in Physics, 24, 2021. Crossref
-
Mahdy A. M. S., Gepreel K. A., Lotfy Kh., El-Bary A. A., A numerical method for solving the Rubella ailment disease model, International Journal of Modern Physics C, 32, 07, 2021. Crossref
-
Romitti Paul A., Utility of Family History Reports of Major Birth Defects as a Public Health Strategy, Pediatrics, 120, SUPPLEMENT_2, 2007. Crossref
-
Onakewhor Joseph, Maduako Toby Kenneth, Okonofua Friday, Non-HIV Viral Infections in Pregnancy, in Contemporary Obstetrics and Gynecology for Developing Countries, 2021. Crossref
-
Xu Jiuyue, Kong Jing, Lyu Bao, Wang Xiaotong, Qian Qi, Zhou Xi, Qiu Yang, The Capsid Protein of Rubella Virus Antagonizes RNA Interference in Mammalian Cells, Viruses, 13, 2, 2021. Crossref
-
Atkins Gregory J., Viruses in the etiology of MS, in The Biology of Multiple Sclerosis, 2012. Crossref
-
Xu Changjin, Saifullah Sayed, Ali Amir, Adnan , Theoretical and numerical aspects of Rubella disease model involving fractal fractional exponential decay kernel, Results in Physics, 34, 2022. Crossref
-
Jash Sukanta, Sharma Surendra, Viral Infections and Temporal Programming of Autism Spectrum Disorders in the Mother's Womb, Frontiers in Virology, 2, 2022. Crossref
-
Boucoiran Isabelle, Castillo Eliana, No 368 - La rubéole durant la grossesse, Journal of Obstetrics and Gynaecology Canada, 40, 12, 2018. Crossref
-
Boucoiran Isabelle, Castillo Eliana, No. 368-Rubella in Pregnancy, Journal of Obstetrics and Gynaecology Canada, 40, 12, 2018. Crossref
-
Zhang Ning, Cheng Xiaodong, Zhou Shujie, Wang Binbing, Luo Xianwei, Chai Yu, Tang Jihai, Su Bin, Liu Zhirong, Epidemiological investigation and prevention and control strategies of rubella in Anhui province, China, from 2012 to 2021, Frontiers in Public Health, 10, 2022. Crossref
-
Dehingia Kaushik, Yao Shao-Wen, Sadri Khadijeh, Das Anusmita, Sarmah Hemanta Kumar, Zeb Anwar, Inc Mustafa, A study on cancer-obesity-treatment model with quadratic optimal control approach for better outcomes, Results in Physics, 42, 2022. Crossref